Age-Related Macular Degeneration
Phase III squalamine trials slated for early 2005
Published in Medical Letter on the CDC and FDA, May 23rd, 2004
The IND covers treatment of neovascular diseases of the eye, including subfoveal choroidal neovascularization associated with age-related macular degeneration, known as "wet" AMD. Genaera also announced they plan to begin phase II trials in AMD this quarter, and these phase II trials will run concurrently with the start of phase III trials in AMD, beginning in early 2005.
"One of Genaera's highest priorities is expediting squalamine's...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Hepatitis C Epidemiology
Risk factors for hepatitis C in Alaska natives reported - Hepatology
Chronic liver disease mortality in the United States reported - Malaria Transmission
Isonicotinic acid hydrazide inhibits malaria transmission in mosquito - Malaria Vaccine
Plasmodium falciparum peptides bind to human hepatocytes - Pancreatic Cancer
No link found between IGF or IGF-binding protein and pancreatic cancer - AIDS Therapy
FDA-approved study launched to treat AIDS patients in virologic failure - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
